Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/120744Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Lopes, C | |
| dc.creator | Gomes, C | |
| dc.creator | Neto, E | |
| dc.creator | Sampaio, P | |
| dc.creator | Aguiar, P | |
| dc.creator | Pêgo, AP | |
| dc.date.accessioned | 2019-06-25T12:08:42Z | - |
| dc.date.available | 2019-06-25T12:08:42Z | - |
| dc.date.issued | 2016 | |
| dc.identifier.issn | 1743-5889 | |
| dc.identifier.uri | https://hdl.handle.net/10216/120744 | - |
| dc.description.abstract | Aim: Propose a nanoparticle for neuron-targeted retrograde gene delivery and describe a microfluidic-based culture system to provide insight into vector performance and safety. Methods: Using compartmentalized neuron cultures we dissected nanoparticle bioactivity upon delivery taking advantage of (quantitative) bioimaging tools. Results: Targeted and nontargeted nanoparticles were internalized at axon terminals and retrogradely transported to cell bodies at similar average velocities but the former have shown an axonal flux 2.7-times superior to nontargeted nanoparticles, suggesting an improved cargo-transportation efficiency. The peripheral administration of nanoparticles to axon terminals is nontoxic as compared with their direct administration to the cell body or whole neuron. Conclusion: A neuron-targeted nanoparticle system was put forward. Microfluidic-based neuron cultures are proposed as a powerful tool to investigate nanoparticle bio-performance. | |
| dc.description.sponsorship | The work was financed by Portuguese funds through the FCT – Fundação para a Ciência e a Tecnologia in the framework of the projects PTDC/CTM-NAN/115124/2009 and PTDC/CTM-NAN/3547/2014. CDF Lopes, CP Gomes and E Neto acknowledge the FCT for their PhD scholarships(SFRH/BD/77933/2011, SFRH/BD/77930/2011 and SFRH/BD/81152/2011, respectively). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. | |
| dc.language.iso | eng | |
| dc.publisher | Future Medicine | |
| dc.relation | info:eu-repo/grantAgreement/FCT/5876-PPCDTI/115124/PT | |
| dc.relation | info:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F77933%2F2011/PT | |
| dc.relation | info:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F81152%2F2011/PT | |
| dc.relation.ispartof | Nanomedicine, vol. 11(24), p. 3205-3221 | |
| dc.rights | openAccess | |
| dc.subject | gene delivery | |
| dc.subject | microfluidics | |
| dc.subject | targeted nanoparticles | |
| dc.title | Microfluidic-based platform to mimic the in vivo peripheral administration of neurotropic nanoparticles | |
| dc.type | Artigo em Revista Científica Internacional | |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | |
| dc.identifier.doi | 10.2217/nnm-2016-0247 | |
| dc.relation.publisherversion | https://www.futuremedicine.com/doi/abs/10.2217/nnm-2016-0247?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=nnm | |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Microfluidicbasedplatformtomimictheinvivo.pdf | 1.08 MB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
